Preclinical characterization of allogeneic CAR ?d T Cell therapy for prostate cancer targeting a novel dimeric epitope on PSMA

被引：0
|
作者：
Ramadoss, Nitya S.
Speltz, Elizabeth
Capillo, Tonya
Meaddough, Erika
Wang, Katherine
Friedland, Natalia
Wong, Jonathan
Teague, Alexander G.
Azameera, Aruna
Gundurao, Smitha Rao Yelaguli
Kaur, Ramandeep
Smith-Boeck, Morgan
Salum, Michael
Chanthery, Yvan
Green, Shon
Herrman, Marissa
Nishimoto, Kevin P.
Aftab, Blake T.
Bhat, Arun
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-C117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C117
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
    Yogindra Vedvyas
    Jaclyn E. McCloskey
    Yanping Yang
    Irene M. Min
    Thomas J. Fahey
    Rasa Zarnegar
    Yen-Michael S. Hsu
    Jing-Mei Hsu
    Koen Van Besien
    Ian Gaudet
    Ping Law
    Nak Joon Kim
    Eric von Hofe
    Moonsoo M. Jin
    Scientific Reports, 9
  • [32] Chimeric Antigen Receptor T Cell (CAR - T) Therapy - A Novel Treatment in Cancer
    Baskaran, Priyadarsini
    Karthikeayan, Venkatraman
    Natarajan, Anusha
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2018, 23 (04)
  • [33] Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
    Vedvyas, Yogindra
    McCloskey, Jaclyn E.
    Yang, Yanping
    Min, Irene M.
    Fahey, Thomas J.
    Zarnegar, Rasa
    Hsu, Yen-Michael S.
    Hsu, Jing-Mei
    Van Besien, Koen
    Gaudet, Ian
    Law, Ping
    Kim, Nak Joon
    von Hofe, Eric
    Jin, Moonsoo M.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [34] Development of CAR T cell therapy targeting glypican-3 in liver cancer
    Dan Li
    Nan Li
    Yifan Zhang
    Haiying Fu
    Madeline B.Torres
    Tim F.Greten
    Mitchell Ho
    Cancer Biology & Medicine, 2018, 15(S1) (S1) : 17 - 17
  • [35] Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell Malignancies
    Ge, Jianning
    Yang, Chunhui
    Sun, Jing
    Chen, Jiao
    Qiu, Shuyi
    Yin, Wenjie
    Shen, Lianjun
    Sersch, Martina
    Cao, Wei
    Wang, Xinxin
    BLOOD, 2021, 138
  • [36] Preclinical in vivo characterization underpinning LGR5-targeting CAR-T cells as a cancer immunotherapy
    Foeng, Jade
    Tyllis, Timona
    Abbott, Caitlin
    McPeake, Dylan
    Thompson, Emma
    Bandara, Veronika
    Gundsambuu, Batjargal
    Napoli, Silvana
    Bonder, Claudine
    Comerford, Iain
    Sadlon, Tim
    Barry, Simon
    McColl, Shaun
    CANCER RESEARCH, 2024, 84 (06)
  • [37] CAR-T cell therapy: a potential new strategy against prostate cancer
    Schepisi, Giuseppe
    Cursano, Maria Concetta
    Casadei, Chiara
    Menna, Cecilia
    Altavilla, Amelia
    Lolli, Cristian
    Cerchione, Claudio
    Paganelli, Giovanni
    Santini, Daniele
    Tonini, Giuseppe
    Martinelli, Giovanni
    De Giorgi, Ugo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
  • [38] γδ CAR-T cell therapy for bone metastatic castrate resistant prostate cancer
    Frieling, J. S.
    Roselli, E.
    Ramello, M. C.
    Lo, C. H.
    Benzaid, I.
    Lynch, C. C.
    Abate-Daga, D.
    HUMAN GENE THERAPY, 2019, 30 (11) : A68 - A68
  • [39] Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
    Zhenling Deng
    Yanhong Wu
    Wenbo Ma
    Shuren Zhang
    Yu-Qian Zhang
    BMC Immunology, 16
  • [40] Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
    Deng, Zhenling
    Wu, Yanhong
    Ma, Wenbo
    Zhang, Shuren
    Zhang, Yu-Qian
    BMC IMMUNOLOGY, 2015, 16
12345